Best OpenEvidence Alternatives in 2026: 7 Clinical AI Answer Engines and Decision-Support Tools

Glass Health combines ambient scribing and clinical decision support in one product. UpToDate may be worth reviewing when your organization already uses UpToDate as part of its clinical reference workflow. Elsevier says ClinicalKey includes EHR integration and AI-powered answers sourced from trusted, evidence-based content. The DynaMed homepage highlights Dyna AI, Specialties, Alerts, Drug Resources, and Chemo Regimens. AMBOSS promotes AI Mode within its medical knowledge platform for doctors and students. Dr.Oracle describes itself as “The World’s Most Powerful Medical Artificial Intelligence Platform.”

Tool	Best for	Public buying path	Source-backed note
Glass Health	Teams that want ambient scribing plus clinical decision support in one product	Lite free; paid plans from $20/mo	Glass offers ambient scribing, Ambient CDS, published pricing, and SMART on FHIR EHR integration. Glass currently supports Epic, eClinicalWorks, athenahealth, and Elation in read-only workflows, with setup confirmed directly with Glass
UpToDate	Teams that already use UpToDate as a clinical reference starting point	Confirm directly with vendor	Use the existing UpToDate workflow as the starting point and confirm current product naming, pricing, and technical details directly with UpToDate
ClinicalKey AI	Elsevier-oriented organizations	Contact us	Elsevier says ClinicalKey includes EHR integration and AI-powered answers sourced from trusted, evidence-based content
DynaMed	Teams reviewing Dyna AI and related knowledge resources from the DynaMed homepage	Review EBSCO public materials	The cited DynaMed page highlights Dyna AI, Specialties, Alerts, Drug Resources, and Chemo Regimens
AMBOSS AI Mode	Users who want AI Mode inside a medical knowledge platform	5-day free trial	AMBOSS promotes AI Mode within its medical knowledge platform for doctors and students
DoxGPT	Teams keeping DoxGPT on a separate diligence track	Confirm directly with vendor	This revision does not include a sourced product summary for DoxGPT, so request written details directly from the vendor before comparing workflows
Dr.Oracle	Buyers who want another medical-AI platform on the shortlist	Confirm directly with vendor	The homepage describes Dr.Oracle as “The World’s Most Powerful Medical Artificial Intelligence Platform”

DoxGPT remains in this guide as a separate diligence track, but this revision does not include a sourced product summary for it because the active comparison is limited to entries supported by currently verifiable public materials.

Glass Health
UpToDate
ClinicalKey AI
DynaMed
AMBOSS AI Mode
DoxGPT
Dr.Oracle
FAQ

Switch from OpenEvidence to Glass Health

OpenEvidence describes itself as “America’s Official Medical Knowledge Platform” on its homepage and says it is free for verified U.S. HCPs (OpenEvidence). This guide stays focused on adjacent medical knowledge and clinical-support tools, with extra detail on Glass because Glass also brings ambient documentation into the evaluation. If your buying process includes documentation redesign, see our broader best AI medical scribe guide.

Glass Health

What it is: Glass Health combines ambient scribing and clinical decision support. Its product pages also describe Ambient CDS, Consult (Clinical Reference Q&A), Differential Diagnosis, Chart Summarization, and documentation workflows.

Best for: Clinicians, practice leaders, and IT teams that want to evaluate documentation workflow and clinical support together instead of in separate product tracks.

Pricing: Glass Health lists Lite (free), Starter ($20/mo), Pro ($90/mo), and Max ($200/mo) on the pricing page.

EHR integrations: Glass’s EHR integration page says the platform integrates into existing EHR workflows using SMART on FHIR technology and pulls patient data into the AI platform. Glass currently supports Epic, eClinicalWorks, athenahealth, and Elation in read-only workflows. The current Glass implementation pattern is SMART on FHIR Backend Services using the client_credentials grant and system/*.read scope. For athenahealth, eClinicalWorks, and Elation, start with a direct SMART on FHIR review with Glass and your EHR team.

Strengths: The clearest reason to evaluate Glass in an OpenEvidence comparison is that Glass changes the shape of the buying conversation. A lot of “clinical AI answer engine” evaluations begin and end with one question: can the product answer medical questions well enough to deserve a place in daily workflow? Glass matters because it adds a second question that many teams care about just as much: can the same product help with the documentation work happening before, during, and after the clinical question arises? If the answer you need sits in the middle of a visit, a note, a chart review, and a follow-up workflow, the value of evaluating ambient scribing and clinical decision support together becomes obvious.

Glass supports that broader workflow in concrete terms. Glass combines ambient scribing with clinical decision support, clinical reference Q&A, differential diagnosis, chart summarization, real-time audio analysis, diagnostic insights, an evolving differential diagnosis, suggested history questions, suggested physical maneuvers, and preliminary next steps. Taken together, Glass is more than a static lookup tool. It gives clinicians a workflow that can capture the visit, summarize context, and surface decision-support help within the same product evaluation.

That broader workflow is especially useful for organizations that do not want separate committees evaluating separate tools for separate pieces of the same encounter. A clinician champion may care about note quality and time spent after clinic. An operations lead may care about rollout, training, and pricing clarity. An IT or informatics lead may care about integration pattern, data access, and implementation scope. Glass gives those groups one product to review together. Even if a team ultimately decides to phase the rollout, starting from one cross-functional workflow can make evaluation more coherent.

Public pricing also helps early-stage planning. A free Lite tier gives an individual clinician or small pilot group a simple way to test fit. Starter, Pro, and Max give practices a visible pricing ladder they can use for rough budget planning before a formal enterprise conversation. Public pricing does not replace formal review, but it does make initial shortlist work easier. A practice administrator can map a pilot budget. A department leader can estimate how many users they want in the first phase. A clinician champion can test real workflow fit without waiting for a custom quote just to begin the conversation.

The current READ-ONLY EHR model is another important part of the evaluation. In Glass, the integration is based on SMART on FHIR Backend Services with client_credentials and system/*.read. That means the product can retrieve read-only context from supported EHR environments while write-back, chart signing, ordering, and final chart authority stay in the native EHR workflow. For some organizations, that is a meaningful deployment advantage in phase one. It gives teams a way to evaluate clinical-context retrieval without simultaneously expanding the write surface area of the implementation. If your governance process is cautious about write access, a read-only starting point can make the pilot easier to scope and easier to review.

Glass is also a strong fit when the evaluation is explicitly about workflow consolidation. Instead of evaluating an answer engine on one track and a documentation tool on another, Glass lets you test whether those jobs belong together. That can matter in ambulatory groups, specialist practices, and health systems where clinicians want fewer app boundaries during the day, not more. The question becomes less “Which answer tool should we add?” and more “What workflow do we want clinicians to live in during the encounter?” Glass is most compelling when that broader question is the one your team is actually trying to solve.

How to enable Glass

A practical Glass rollout usually follows a straightforward sequence:

Start with the right plan for the pilot. Lite is the easiest entry point for individual testing. Starter, Pro, and Max make more sense when the pilot already has a defined team, department, or expansion path.
Confirm the supported EHR environment. Glass currently supports Epic, eClinicalWorks, athenahealth, and Elation in read-only workflows, and the non-Epic workflows are assisted setup paths confirmed directly with Glass.
Set up SMART on FHIR Backend Services. The key technical pieces are the Backend Services pattern, the client_credentials grant, and the system/*.read scope.
Define the read-only context you need. Before the pilot begins, decide which patient-context workflows matter most: ambient documentation, chart review, summarization, consult-style Q&A, or Ambient CDS support during the encounter.
Coordinate implementation directly with Glass. For Epic, that means aligning registration and workflow validation with your Epic team and Glass. For athenahealth, eClinicalWorks, and Elation, work directly with Glass on the implementation path.
Pilot the complete workflow, not just access. A successful test should cover how clinicians use the product from conversation capture to note generation to chart summarization to clinical-support prompts, not just whether data can be reached.
Expand only after workflow validation. Once the pilot confirms fit, then move from individual use to broader operational deployment.

Weaknesses: The central tradeoff is the current READ-ONLY integration posture. If your organization requires write-back, in-chart signing, ordering actions, or a deeper in-EHR execution model on day one, validate present-day workflow fit directly with Glass before rollout. Teams should also be deliberate about pilot design. Because Glass spans documentation and clinical support, a weak pilot can under-test the product by looking at only one slice of the workflow. The more useful evaluation is the full one: whether the combined note, context, and decision-support experience works for the clinicians who will actually use it.

Switch from OpenEvidence if... you want to compare a product that combines ambient scribing and clinical decision support in one workflow. Start with Glass’s pricing, EHR integration, OpenEvidence comparison, and Ambient CDS pages, then test whether that combined workflow fits your team.

UpToDate

What it is: This slot relies on the public UpToDate homepage, so the summary here is intentionally limited. If your organization already uses UpToDate, use that existing reference workflow as a starting point and confirm current product naming, pricing, and technical details directly with the vendor.

Best for: Teams that already have an UpToDate-centered clinical reference process and want to use that installed workflow as the starting point for diligence.

Pricing: Confirm current pricing directly with UpToDate.

EHR integrations: Confirm current technical details directly with UpToDate.

Strengths: The practical appeal here is continuity. If clinicians, library teams, and medical leadership already rely on UpToDate, starting from that existing workflow can simplify the internal conversation. You are not beginning from zero familiarity. In many organizations, that means the real diligence questions shift toward fit, governance, and operational details rather than basic brand adoption.

Weaknesses: Because this guide is intentionally limited to source-backed public wording, the public homepage is not enough to answer product-naming, packaging, provenance, administrative-control, security, or deployment questions. Buyers should ask UpToDate to provide the exact materials that apply to their environment before making a replacement decision.

Switch from OpenEvidence if... you want to start from an existing UpToDate reference workflow and confirm current product naming, pricing, and technical details directly with the vendor.

ClinicalKey AI

What it is: Elsevier describes ClinicalKey within its evidence-based decision-support portfolio, and the cited page says clinicians can “Find answers faster with ClinicalKey AI Powered by responsible AI... sourced from trusted, evidence-based content” (ClinicalKey).

Best for: Health systems, groups, and library teams that already buy into Elsevier content and want to review AI answers inside that ecosystem.

Pricing: Contact us (ClinicalKey).

EHR integrations: Elsevier says ClinicalKey includes EHR integration and can be embedded into clinical workflow (ClinicalKey).

Strengths: ClinicalKey is a sensible shortlist entry when the buying conversation already runs through Elsevier relationships and content strategy. The public positioning is clear on the points many institutions care about most: evidence-based content, AI-powered answers, and workflow embedding through EHR integration. For teams that want their answer workflow to stay close to an established content vendor, that is a straightforward reason to include ClinicalKey in evaluation.

Weaknesses: Buyers should still ask Elsevier to show the specific package, implementation path, and administrative controls that would apply in their environment. Public positioning helps with shortlist formation, but enterprise teams usually need a more concrete view of the exact workflow they would deploy.

Switch from OpenEvidence if... your institution already uses Elsevier content heavily and you want to compare that workflow directly against OpenEvidence and Glass.

DynaMed

What it is: For this slot, the cited public source is the DynaMed homepage. That page highlights Dyna AI, Specialties, Alerts, Drug Resources, and Chemo Regimens.

Best for: Buyers who want to include DynaMed on the shortlist and review how Dyna AI and related knowledge resources fit their clinical workflow.

Pricing: Use EBSCO’s public DynaMed materials to confirm current packaging and pricing details.

EHR integrations: Use EBSCO’s public DynaMed materials to evaluate current deployment details.

Strengths: DynaMed is worth evaluating when the organization wants a reference-oriented option that publicly emphasizes not only AI but also adjacent knowledge resources such as alerts, drug resources, and chemo regimens. That broader homepage framing can matter in hospital settings and medication-intensive environments where the knowledge workflow is wider than one question type.

Weaknesses: Because this article is intentionally limited to source-backed public wording, buyers should ask EBSCO to show the exact package, answer workflow, security posture, and deployment approach that would apply to their clinicians. The homepage is useful for shortlist formation, but it does not replace implementation diligence.

Switch from OpenEvidence if... you want DynaMed on the shortlist and plan to evaluate Dyna AI and related resources directly from EBSCO’s current public materials.

AMBOSS AI Mode

What it is: AMBOSS describes itself as a medical knowledge platform for doctors and students and promotes AI Mode, with public language that the platform is “enhanced by the latest AI technology” (AMBOSS).

Best for: Teaching hospitals, residency-heavy groups, and clinicians who want to review AI Mode inside a broader knowledge platform.

Pricing: AMBOSS promotes a 5-day free trial and a public Pricing path on its site (AMBOSS).

EHR integrations: Confirm package and deployment details directly with AMBOSS.

Strengths: AMBOSS is especially relevant where learning and point-of-care support overlap. The public positioning is not only about AI; it is about AI Mode inside a knowledge platform already aimed at doctors and students. That makes it a practical shortlist entry for environments with trainees, teaching responsibilities, or clinicians who prefer concise, high-yield support inside a broader learning workflow.

Weaknesses: Buyers should still verify which package includes the exact workflow they want, how institutional access is handled, and what deployment model is appropriate for their setting. Those details are what determine whether the platform works for a real clinical environment rather than a general exploration phase.

Switch from OpenEvidence if... your team wants to compare OpenEvidence with a medical knowledge platform that publicly promotes AI Mode and a free trial.

DoxGPT

This version does not include a sourced product summary for DoxGPT. That does not mean DoxGPT cannot belong on an internal shortlist; it means this page is limited to products supported by currently verifiable public materials for the claims made here.

If DoxGPT is on your internal list, treat it as a separate diligence track and request written details on pricing, provenance, security, data handling, and deployment before making a decision. In practice, that means asking for current product documentation, implementation steps, and contract language directly from the vendor, then evaluating those materials against the same checklist you use for every other tool on the shortlist.

Dr.Oracle

What it is: The Dr.Oracle homepage describes the product as “The World’s Most Powerful Medical Artificial Intelligence Platform.”

Best for: Buyers who want another medical-AI platform on the shortlist and are comfortable validating details directly with the vendor.

Pricing: Confirm directly with Dr.Oracle.

EHR integrations: Confirm deployment details directly with Dr.Oracle.

Strengths: Dr.Oracle is a reasonable vendor to review if your evaluation process is broad and you want to look beyond the largest incumbent knowledge brands. The public positioning is expansive, which can make it appropriate as an exploratory shortlist candidate when the goal is to survey the market before narrowing the field.

Weaknesses: Before purchase, confirm pricing, provenance, security, and deployment details directly with Dr.Oracle. Those are the questions that determine whether the product fits real clinical operations, and the homepage alone is not enough to answer them.

Switch from OpenEvidence if... you want another medical-AI platform on the shortlist and are prepared to validate the details directly with the vendor.

Why switch from OpenEvidence to Glass Health

OpenEvidence says it is “America’s Official Medical Knowledge Platform” and that it is free for verified U.S. HCPs on its homepage (OpenEvidence). Glass belongs in the same evaluation set when your team wants to review a workflow that combines ambient scribing and clinical decision support in one product. That is the core reason to include Glass in an OpenEvidence comparison: Glass itself covers documentation workflow, Ambient CDS, clinical reference Q&A, differential diagnosis, chart summarization, and EHR-connected context retrieval in the same deployment discussion.

That matters most when the evaluation is being run by more than one stakeholder group. A clinician champion may care about note quality and after-hours charting burden. Operations may care about rollout path and pricing clarity. IT may care about access model, implementation sequencing, and how much change is being introduced into the EHR environment. Glass gives those groups one product to assess together instead of forcing the organization to split the encounter into separate evaluation tracks.

Glass also gives buyers a more concrete pilot path than many broad market scans do. The published pricing ladder makes it easier to sketch an initial rollout. The product pages give a clear enough workflow picture to run a real evaluation around ambient documentation, chart summarization, Q&A, and Ambient CDS. And the current EHR model is specific: Glass supports Epic, eClinicalWorks, athenahealth, and Elation in read-only workflows via SMART on FHIR Backend Services using client_credentials and system/*.read. For organizations that want clinical context available in the product while keeping write actions inside the EHR, that deployment posture can be a useful starting point.

There is also a practical implementation angle. For athenahealth, eClinicalWorks, and Elation, buyers should start implementation planning with a direct conversation with Glass and confirm the current pathway for their environment. That is not a drawback so much as a planning reality: if Glass is on your shortlist, include the implementation conversation early rather than assuming that another listing surface defines the rollout.

If you want to test that workflow directly, start with the OpenEvidence comparison, then review pricing, EHR integrations, and Ambient CDS. If your project also includes documentation redesign, see our broader AI medical scribe guide.

Switch from OpenEvidence to Glass Health

FAQ

Is OpenEvidence HIPAA compliant?

Use OpenEvidence’s own website and contracting materials as the source of truth for current compliance language, BAA availability, and deployment terms (OpenEvidence). For any clinical rollout, legal and security teams should verify how PHI is handled, what contract terms apply, and whether there are implementation constraints before assuming production readiness from marketing copy alone.

Which OpenEvidence alternative can I try first at no cost?

Glass Health is an easy place to start if you want to test a broader workflow at no cost because it offers a Lite tier on the pricing page. That gives individual clinicians or small teams a practical way to evaluate ambient scribing and clinical decision support together before moving to a paid plan.

Does Glass Health integrate with Epic, eClinicalWorks, athenahealth, and Elation?

Yes. Glass supports Epic, eClinicalWorks, athenahealth, and Elation in read-only workflows. The workflow uses SMART on FHIR Backend Services with client_credentials and system/*.read (EHR integration, OpenEvidence comparison). Elation and the non-Epic workflows are assisted setup paths confirmed directly with Glass.

How does Glass Health compare to OpenEvidence on price?

Glass Health lists Lite (free), Starter ($20/mo), Pro ($90/mo), and Max ($200/mo) on the pricing page. OpenEvidence says it is free for verified U.S. HCPs on its homepage (OpenEvidence). For a real buying decision, confirm current packaging, contract terms, and deployment scope directly with both vendors.

Can I trial Glass Health before switching from OpenEvidence?

Yes. The simplest way to test Glass is the public Lite tier on the pricing page. That lets clinicians or small teams evaluate workflow fit first, then move to Starter, Pro, or Max if they need broader deployment.

What does Glass Health combine in one product?

Glass combines ambient scribing and clinical decision support, including Ambient CDS, clinical reference Q&A, differential diagnosis, chart summarization, and documentation workflows (Glass Health, features, Ambient CDS). Glass also supports READ-ONLY EHR integrations for supported environments.

How do I enable Glass Health in the EHR?

Start by choosing the Glass plan that matches your pilot, then work with Glass and your IT team on a READ-ONLY SMART on FHIR Backend Services setup using client_credentials and system/*.read (pricing, EHR integration). For Epic, eClinicalWorks, athenahealth, and Elation, confirm the current implementation steps directly with Glass.